ProPhase Labs, Inc.
PRPHNASDAQHealthcare● Active
$0.10
$-0.01(-9.09%)
Market Cap$473701
P/E Ratio—
52W High$6.7
52W Low$0.07
ProPhase Labs, Inc. (PRPH) · Balance Sheet
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · PRPH · as of 2026-06-10
Financial statements
Total Assets · Total Liabilities · Equity
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $0.09M | $0.68M | $4.74M | $17.44M | $17.51M |
| Net Receivables | $1.54M | $20.06M | $35.81M | $37.05M | $37.71M |
| Inventory | $0.00M | $1.14M | $2.29M | $3.98M | $4.60M |
| Total Current Assets | $3.15M | $30.64M | $47.59M | $60.83M | $61.32M |
| PP&E Net | $0.00M | $11.62M | $14.90M | $11.35M | $10.35M |
| Goodwill | $3.97M | $5.23M | $5.23M | $5.71M | $5.71M |
| Intangible Assets | $7.17M | $9.75M | $12.33M | $8.47M | $10.85M |
| Total Assets | $59.87M | $63.20M | $91.93M | $87.65M | $89.30M |
| Liabilities | |||||
| Short-Term Debt | $5.16M | $6.57M | $2.79M | $0.30M | $0.66M |
| Accounts Payable | $12.96M | $13.72M | $8.64M | $5.91M | $7.03M |
| Total Current Liabilities | $53.08M | $32.13M | $20.86M | $16.07M | $15.52M |
| Long-Term Debt | $0.00M | $11.65M | $7.33M | $2.40M | $10.04M |
| Total Liabilities | $56.36M | $55.85M | $42.54M | $24.02M | $30.67M |
| Stockholders Equity | |||||
| Retained Earnings | ($73.14M) | ($58.39M) | ($5.03M) | $11.75M | $2.64M |
| Total Stockholders Equity | $3.51M | $7.35M | $49.38M | $63.63M | $58.63M |
| Total Liab & Equity(computed) | $59.87M | $63.20M | $91.93M | $87.65M | $89.30M |
| Debt Summary | |||||
| Total Debt | $8.62M | $24.57M | $18.46M | $6.96M | $14.90M |
| Net Debt | $8.53M | $23.89M | $16.85M | ($2.15M) | $6.24M |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · M
Explore more ProPhase Labs, Inc. data
About ProPhase Labs, Inc. (PRPH) Balance Sheet
ProPhase Labs, Inc. (PRPH) balance sheet shows total assets of $0.06B with cash of $0.00B. Total liabilities are $0.06B, total debt $0.01B, and stockholders equity $0.00B.
Frequently asked questions
PRPH · 4 questionsProPhase Labs, Inc. has total debt of $0.01B with net debt of $0.01B.
PRPH total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10